Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades

Clinical Infectious Diseases

Volumn 50, Issue 3, 2010, Pages 329-337

  Harboe, Zitta B ^a   Benfield, Thomas L ^c,d   Valentiner Branth, Palle ^b   Hjuler, Thomas ^a   Lambertsen, Lotte ^a   Kaltoft, Margit ^a   Krogfelt, Karen ^a   Slotved, Hans Christian ^a   Christensen, Jens Jørgen ^a   Konradsen, Helle B ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b Department of Epidemiology ^*  (Denmark)

^c HVIDOVRE HOSPITAL   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM; ERYTHROMYCIN; HAEMOPHILUS INFLUENZAE VACCINE; MACROLIDE; PENICILLIN G; PNEUMOCOCCUS VACCINE;

AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIAL MENINGITIS; CHILD; DENMARK; EPIDEMIC; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DENMARK; FEMALE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; RETROSPECTIVE STUDIES; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; YOUNG ADULT;

EID: 75749099291     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/649872     Document Type: Article

References (43)

1. Henrkhsen J. Sk newly recognized types of Streptococcus pneumoniae. J Clin Microbiol 1995;33(10):2759-2762.
2. Park IH, Pritchard DG, Cartee R, Brandao A, Brandileone MC, Nahm MH. Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae. J Clin Microbiol 2007;45(4):1225-1233.
3. Fedson DS, Musher DM. Pneumococcal polysaccharide vaccine. In: Plotkin SA, Orenstein WA, eds. Vaccines. 4th ed. Philadelphia, PA: Elsevier, 2004:529-588.
4. Hausdorff WP, Feikin DR, Klugman KP. Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis 2005;5(2):83-93.
5. Harboe ZB, Thomsen RW, Riis A, et al. Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study. PLoS Med 2009;6(5):e1000081.
6. 6. Hjuler T, Wohlfahrt J, Simonsen J, et al. Perinatal and crowding-related risk factors for invasive pneumococcal disease in infants and young children: a population-based case-control study. Clin Infect Dis 2007; 44(8):1051-1056. (Pubitemid 46580271)
7. Dagan R, Klugman KP. Impact of conjugate pneumococcal vaccines on antibiotic resistance. Lancet Infect Dis 2008;8(12):785-795.
8. Singleton RJ, Hennessy TW, Bulkow LR, et al. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 2007;297(16):1784-1792.
9. Klugman KP, Madhi SA. Pneumococcal vaccines and flu preparedness. Science 2007;316(5821):49-50.
10. Grijalva CG, Nuorti JP, Arbogast PG, Martin SW, Edwards KM, Griffin MR. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet 2007;369(9568):1179-1186.
11. 11. Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003;348(18):1737-1746. (Pubitemid 36514704)
12. Guevara M, Barricarte A, Perez B, Arriazu M, Garcia CM, Castilla J. Heptavalent-pneumococcal conjugate vaccine (Prevenar). Differences in effectiveness between populations [in Spanish]. An Sist Sanit Navar 2008;31(2):171-192.
13. Hicks LA, Harrison LH, Flannery B, et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis 2007; 196(9):1346-1354.
14. Danmarks Statistik. http://www.dst.dk. Accessed 14 December 2009.
15. Harboe ZB, Valentiner-Branth P, Benfield TL, et al. Estimated effect of pneumococcal conjugate vaccination on invasive pneumococcal disease and associated mortality, Denmark 2000-2005. Vaccine 2008; 26(29-30):3765-3771.
16. Konradsen HB. Pneumokokvaccination [Pneumococcal vaccination]. EPI-NEWS 1996; week 16 and week 51.
17. Danish Medicines Agency., http://www.dkma.dk. Accessed 14 December 2009.
18. Kauffmann F, Mørch EL, Schmith K. On the serology of the pneumococcus group. J Immunol 1940;39(5):397-426.
19. Henrichsen J. Typing of Streptococcus pneumoniae: past, present, and future. Am J Med 1999;107(1A):50S-54S.
20. Sorensen UB. Typing of pneumococci by using 12 pooled antisera. J Clin Microbiol 1993;31(8):2097-2100.
21. Meyer CN, Schonheyder HC, Bangsborg J, et al. Bacterial meningitis in Denmark 2002-2003. A nation-wide laboratory-based registration. Ugeskr Laeger 2007; 169(6):503-506.
22. Henrichsen J, Konradsen HB, Nielsen SV, Skinhoj P. Increased occurrence of pneumococcal bacteremia in Denmark. Ugeskr Laeger 1997; 159(23):3615-3616.
23. Pedersen CB, Gotzsche H, Moller JO, Mortensen PB; Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull 2006;53(4):441-449.
24. DANMAP 2007 - Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, foods and humans in Denmark. http://www.danmap.org. Accessed 14 December 2009.
25. Hammerum AM, Heuer OE, Emborg HD, et al. Danish integrated antimicrobial resistance monitoring and research program. Emerg Infect Dis 2007; 13(11):1632-1639.
26. Gonzalez BE, Hulten KG, Lamberth L, Kaplan SL, Mason EO Jr. Streptococcus pneumoniae serogroups 15 and 33: an increasing cause of pneumococcal infections in children in the United States after the introduction of the pneumococcal 7-valent conjugate vaccine. Pediatr Infect Dis J 2006;25(4):301-305.
27. Jacobs MR, Good CE, Bajaksouzian S, Windau AR. Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine. Clin Infect Dis 2008;47(11):1388-1395.
28. DANMAP 2003 - Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, foods and humans in Denmark. http://www.danmap.org. Accessed 14 December 2009.
29. Samuelsson S, Gustavsen S, Ronne T. Epidemiology of meningococcal disease in Denmark 1980-1988. Scand J Infect Dis 1991; 23(6):723-730.
30. Aszkenasy OM, George RC, Begg NT. Pneumococcal bacteraemia and meningitis in England and Wales 1982 to 1992. Commun Dis Rep CDR Rev 1995;5(4):R45-R50.
31. Nielsen SV, Henrichsen J. Incidence of invasive pneumococcal disease and distribution of capsular types of pneumococci in Denmark, 1989-1994. Epidemiol Infect 1996;117(3):411-416.
32. Frimodt-Moller N, Espersen F, Skinhoj P, Rosdahl VT. Epidemiology of Staphylococcus aureus bacteremia in Denmark from 1957 to 1990. Clin Microbiol Infect 1997;3(3):297-305.
33. Schonheyder HC, Sorensen HT, Kristensen B, Korsager B. Reasons for increase in pneumococcal bacteraemia. Lancet 1997;349(9064):1554.
34. Kallenius G, Hedlund J, Svenson SB, Kalin M, Henrichsen J. Pneumococcal bacteraemia in Sweden. Lancet 1997;349(9069):1910.
35. Giesecke J, Fredlund H. Increase in pneumococcal bacteraemia in Sweden. Lancet 1997; 349(9053) :699-700.
36. Klemets P, Lyytikainen O, Ruutu P, et al. Trends and geographical variation in invasive pneumococcal infections in Finland. Scand J Infect Dis 2008;40(8):621-628.
37. Feikin DR, Klugman KP. Historical changes in pneumococcal serogroup distribution: implications for the era of pneumococcal conjugate vaccines. Clin Infect Dis 2002;35(5):547-555.
38. 38. Lohse N, Hansen AB, Jensen-Fangel S, et al. Demographics of HIV-1 infection in Denmark: results from the Danish HIV Cohort Study. Scand J Infect Dis 2005;37(5):338-343. (Pubitemid 40691514)
39. Jefferson T, Ferroni E, Curtale F, Giorgi Rossi P, Borgia P. Streptococcus pneumoniae in western Europe: serotype distribution and incidence in children less than 2 years old. Lancet Infect Dis 2006;6(7):405-1110
40. Evers S, Ament A, Colombo G, et al. Cost-effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease in the elderly: an update for 10 western European countries. Eur J Clin Microbiol Infect Dis 2007; 26(8) :531-540.
41. Choi EH, Kim SH, Eun BW, et al. Streptococcus pneumoniae serotype 19A in children, South Korea. Emerg Infect Dis 2008; 14(2):275-281.
42. Dagan R, Givon-Lavi N, Leibovitz E, Greenberg D, Porat N. Introduction and proliferation of multidrug-resistant Streptococcus pneumoniae serotype 19A clones that cause acute otitis media in an unvaccinated population. J Infect Dis 2009; 199(6):776-785.
43. European Antimicrobial Resistance Surveillance System (EARSS). EARSS interactive database access. http://www.rivm.nl/earss/database/. Accessed 14 December 2009.